H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,444 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
根据最新的财务报表(Form-10K),H.U. Group Holdings, Inc. 的总资产为 $279,582,净利润为 $2,761
MRCHF 的关键财务比率是什么?
H.U. Group Holdings, Inc. 的流动比率是 1.96,净利 margin 为 1.13,每股销售为 $4,277.2。
H.U. Group Holdings, Inc. 的收入按细分市场或地理位置如何划分?
H.U. Group Holdings, Inc. 最大收入来源是 Inspection and Related Service,在最近的收益报告中收入为 153,014,000,000。就地区而言, Japan 是 H.U. Group Holdings, Inc. 的主要市场,收入为 206,215,000,000。
H.U. Group Holdings, Inc. 是否盈利?
是的,根据最新的财务报表,H.U. Group Holdings, Inc. 的净利润为 $2,761